12+ Aged Children to Be Vaccinated From October with Zycov-D
A big update for ZyCoV-D got clearance from the Indian regulators last month. ZyCoV-D is the world's first DNA based Coronavirus vaccine.
All children in India aged 12 or above will be eligible for
the Covid vaccine shots from October, after the drugmaker Cadila Healthcare introduces
its ZyCoV-D product.
Zydus Cadila from next month will manufacture around 10
million doses of Coronavirus vaccines each month.
The Zydus vaccine is the only vaccine approved for
adolescents in India. The firm has already provided nearly 825.9 million shots
to adults among its population of nearly 1.4 billion.
Also Read: Covid
vaccination for kids by September, informs ICMR-NIV director
Zydus Cadila's ZyCoV-D is a 'plasmid DNA' vaccine that uses
a non-replicating version of a DNA molecule named a plasmid. This process helps
to prepare a harmless version variant of the spike protein which is present on
the SARS-COV-2 membrane. The procedure is also known as the third generation
vaccine, a DNA based vaccine that uses engineered DNA to produce an immune
response against the virus after it is administered to the body.
The World Health Organisation had called Zydus’s vaccine a
"radical new approach" which offers several benefits over the
traditional vaccines using syringes including "improved vaccine stability,
the absence of any infectious agent and the relative ease of large-scale
manufacture."
Zydus Cadila had received approval for Emergency Use
Authorisation (EUA) from the Drug Controller General of India (DCGI) on 20
August, which is in the third phase of the trial.
The ZyCoV-D is a needle-free vaccine that is given using a
needle-free applicator, to make sure the recipient suffers less pain.
Also Read: Five
must-know facts about Zydus Cadila’s covid Vaccine for children above 12
Zydus has developed the vaccine in India by partnering with
the Department of Biotechnology, making it the second homegrown shot after
Bharat Biotech's Covaxin.
Comments
Post a Comment